In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD

Journal of Cerebral Blood Flow and Metabolism

Volumn 27, Issue 7, 2007, Pages 1407-1415

  Sossi, Vesna ^a   Holden, James E ^b   Topping, Geoffrey J ^a   Camborde, Marie Laure ^a   Kornelsen, Rich A ^a   McCormick, Siobhan E ^a   Greene, Jennifer ^c   Studenov, Andrei R ^c   Ruth, Thomas J ^c   Doudet, Doris J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c TRIUMF   (Canada)

Author keywords

PET imaging; 6 OHDA PD rat model; Affinity; Density; DTB2

Indexed keywords

CARBON 11; DIHYDROTETRABENAZINE; MONOAMINE; OXIDOPAMINE; VESICULAR TRANSPORT PROTEIN;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEASIBILITY STUDY; MALE; MEASUREMENT; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SCATCHARD PLOT;

ADRENERGIC AGENTS; ANIMALS; BRAIN; CARBON RADIOISOTOPES; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; OXIDOPAMINE; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TETRABENAZINE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 34250807691     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600446     Document Type: Article

References (22)

1. 3/KF or tetrabutylammonium fluoride asa base. J Labelled Comp Radiopharm 42(Suppl):S445-7
2. Breese GR, Traylor TD (1971) Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Br J Pharmacol 42:88-99
3. Delforge J, Bottlaender M, Pappata S, Loc'h C, Syrota A (2001) Absolute quantification by positron emission tomography of the endogenous ligand. J Cereb Blood Flow Metab 21:613-30
4. Holden JE, Jivan S, Ruth TJ, Doudet DJ (2002) In vivo receptor assay with multiple ligand concentrations: an equilibrium approach. J Cereb Blood Flow Metab 11:1132-41
5. Kelly PH, Iversen SD (1976) Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45-56
6. Kemmerer ES, Desmond TJ, Albin RL, Kilbourn MR, Frey KA (2003) Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole. Exp Neurol 183:81-6
7. Kilbourn M, Lee L, Vander Borght T, Jewett D, Frey K (1995) Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific. Eur J Pharmacol 278:249-52
8. Kilbourn MR, Frey KA, Vander Borght T, Sherman PS (1996) Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters. Nucl Med Biol 23:467-71
9. Kish SJ, Shannak K, Rajput A, Deck JH, Hornykiewicz O (1992) Aging produces a specific pattern of striatal dopamine loss: implications for the ethiology of idiopathic Parkinson's disease. J Neurochem 58:642-8
10. Laforest R, Longford D, Siegel S, Newport D, Yap J (2004) Performance evaluation of the microPET-Focus-F120. IEEE Nucl Sci Symp Conf Rec 2004:2965-9
11. Larsen P, Ulin J, Dahlstrom K, Jensen M (1997) Synthesis of [11C]iodomethane by iodination of [11 C]methane. Appl Radiat Isot 48:153-7
12. 2. Nucl Med Biol 24:93-7
13. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834-40
14. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. San Diego: Academic Press
15. Rehavi M, Goldin M, Roz N, Weizman A (1998) Regulation of rat brain vesicular monoamine transporter by chronictreatment with ovarian hormones. Brain Res Mol Brain Res 57:31-7
16. Rubins DJ, Meadors AK, Yee S, Melega WP, Cherry SR (2001) Evaluation of a stereotactic frame for repositioning of the rat brain in serial positron emission tomography imaging studies. J Neurosci Methods 107:63-70
17. Schoenberg BS, Osuntokun BO, Adeuja AO, Bademosi O, Nottidge V, Anderson DW, Haerer AF (1988) Comparison of the prevalenceof Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 38:645-6
18. Strome EM, Cepeda IL, Sossi V, Doudet DJ (2006) Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography. Mol Imaging Biol 8:292-9
19. Ungerstedt U (1968) 6-Hydrohydopamine-induced degeneration of central monoamine neurons. Eur J Pharmacol 3:5107-10
20. Whishaw IQ, Gorn B, Tran-Nguyen LTL, Casteneda E, Miklyaeva EI, Pellis SM (1994) Making two movements at once: impairments of movement, posture, and their integration underlie the adult skilled reaching deficit of neonatally dopamine-depleted rats. Behav Brain Res 61:65-77
21. Wilson JM, Kish SJ (1996) The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chroniccocaine self-administration in the rat. J Neurosci 16:3507-10
22. Woods RP, Mazziotta JC, Cherry SR (1993) MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17:536-46